Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Human cytomegalovirus persistence.

Goodrum F, Caviness K, Zagallo P.

Cell Microbiol. 2012 May;14(5):644-55. doi: 10.1111/j.1462-5822.2012.01774.x. Epub 2012 Mar 8. Review.

2.

The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?

Wills MR, Poole E, Lau B, Krishna B, Sinclair JH.

Cell Mol Immunol. 2015 Mar;12(2):128-38. doi: 10.1038/cmi.2014.75. Epub 2014 Aug 18. Review.

3.

Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology.

Gredmark-Russ S, Söderberg-Nauclér C.

Virulence. 2012 Nov 15;3(7):621-34. doi: 10.4161/viru.22239. Epub 2012 Oct 17. Review.

4.

Human cytomegalovirus manipulation of latently infected cells.

Sinclair JH, Reeves MB.

Viruses. 2013 Nov 21;5(11):2803-24. doi: 10.3390/v5112803. Review.

5.

Diverse immune evasion strategies by human cytomegalovirus.

Noriega V, Redmann V, Gardner T, Tortorella D.

Immunol Res. 2012 Dec;54(1-3):140-51. doi: 10.1007/s12026-012-8304-8. Review.

PMID:
22454101
6.

Mechanisms of human cytomegalovirus persistence and latency.

Jarvis MA, Nelson JA.

Front Biosci. 2002 Jun 1;7:d1575-82. Review.

PMID:
12045013
7.

Sleepless latency of human cytomegalovirus.

Poole E, Sinclair J.

Med Microbiol Immunol. 2015 Jun;204(3):421-9. doi: 10.1007/s00430-015-0401-6. Epub 2015 Mar 14. Review.

8.

Latency and reactivation of human cytomegalovirus.

Sissons JG, Bain M, Wills MR.

J Infect. 2002 Feb;44(2):73-7. Review.

PMID:
12076064
9.

Human cytomegalovirus latent infection and associated viral gene expression.

Slobedman B, Cao JZ, Avdic S, Webster B, McAllery S, Cheung AK, Tan JC, Abendroth A.

Future Microbiol. 2010 Jun;5(6):883-900. doi: 10.2217/fmb.10.58. Review.

PMID:
20521934
10.

Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures.

Rölle A, Olweus J.

APMIS. 2009 May;117(5-6):413-26. doi: 10.1111/j.1600-0463.2009.02449.x. Review.

PMID:
19400865
11.

[Research Progress in Mechanisms Associated with Latent Infection in Humans by the Cytomegalovirus].

Gao H, Tao R, Yu H, Shang S.

Bing Du Xue Bao. 2016 Jan;32(1):82-7. Review. Chinese.

PMID:
27295888
12.

[Cytomegalovirus (CMV)].

Kosugi I.

Uirusu. 2010 Dec;60(2):209-20. Review. Japanese.

13.

Latency and reactivation of human cytomegalovirus.

Sinclair J, Sissons P.

J Gen Virol. 2006 Jul;87(Pt 7):1763-79. Review.

PMID:
16760381
14.
15.

Epigenetic regulation of human cytomegalovirus latency: an update.

Kumar A, Herbein G.

Epigenomics. 2014;6(5):533-46. doi: 10.2217/epi.14.41. Review.

PMID:
25431945
16.

Cytomegalovirus latency and reactivation: recent insights into an age old problem.

Dupont L, Reeves MB.

Rev Med Virol. 2016 Mar;26(2):75-89. doi: 10.1002/rmv.1862. Epub 2015 Nov 17. Review.

17.
18.

Cytomegalovirus and the aging population.

Emery VC.

Drugs Aging. 2001;18(12):927-33. Review.

PMID:
11888347
19.

Human cytomegalovirus: Latency and reactivation in the myeloid lineage.

Sinclair J.

J Clin Virol. 2008 Mar;41(3):180-5. doi: 10.1016/j.jcv.2007.11.014. Review.

PMID:
18164651
20.

The use of microRNA by human viruses: lessons from NK cells and HCMV infection.

Goldberger T, Mandelboim O.

Semin Immunopathol. 2014 Nov;36(6):659-74. doi: 10.1007/s00281-014-0447-3. Epub 2014 Sep 19. Review.

PMID:
25234555

Supplemental Content

Support Center